Heidelberg Pharma
Ladenburg
About Heidelberg Pharma
Heidelberg Pharma GmbH, a drug development company, provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries. It offers services, such as explorative pharmacology, drug metabolism and pharmacokinetics analysis, and molecular biology in the fields of oncology or inflammatory/autoimmune diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $326.1M
- Funding stage: M&A
- Last round: Post-IPO Debt (Mar 2026)
- Ticker: etr:HPHA
- Website: heidelberg-pharma.com
- Phone: 49 6203 10 09 13
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/heidelberg-pharma-130413 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.